Clinical trial
Single Dose Two-Way Crossover Fasted Bioequivalence Study of Atenolol 100 mg Capsules in Healthy Volunteers
NCT00775580 is registered in ClinicalTrials.gov with Ranbaxy Laboratories Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Dose Two-Way Crossover Fasted Bioequivalence Study of Atenolol 100 mg Capsules in Healthy Volunteers
- Lead sponsor
- Ranbaxy Laboratories Limited
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2005
- Completion date
- July 31, 2005
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy